2022³â °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø¡¤´ëÇÑÀ̽ÄÇÐȸ ¡®±è¼öȯÃß±â°æ ±â³ä¡¯ °øµ¿ÁÖÃÖ ½ÉÆ÷Áö¾ö : 2022-09-03±³À°ÀÏÀÚ : 2022-09-03
±³À°Àå¼Ò : ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç
±³À°ÁÖÁ¦ :
2022³â °¡Å縯´ëÇб³ ÀºÆò¼º¸ðº´¿ø¡¤´ëÇÑÀ̽ÄÇÐȸ ¡®±è¼öȯÃß±â°æ ±â³ä¡¯ °øµ¿ÁÖÃÖ ½ÉÆ÷Áö¾öÁÖÃÖ±â°ü : ´ëÇÑÀ̽ÄÇÐȸ
´ã´çÀÚ : ÀºÆò¼º¸ðº´¿ø
¿¬¶ôó : 02-3144-2227
À̸ÞÀÏ :
info@chiron.co.kr ±³À°Á¾·ù : ³»°ú, ¿Ü°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 6 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 09:10~09:25 Clinical outcomes of KT living donor with chronic disease ¹ÝÅÂÇö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 09:25~09:40 Clinical significanceof ABO-incompatible kidney transplantation in elderly recipients Çã±ÔÇÏ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 09:40~09:55 Unexpected post-KT cardiovascular complication and management ¹Ú¼øö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 09:55~10:10 KT deceased donor with acute kidney injury ¹ÚÀç¹ü(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 10:10~10:30 An overview of the current management of short-bowel syndrome Alan N Langnas(UNMC, Omaha, NE, USA)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 10:30~10:50 Post-transplant management and Graft surveillance in small bowel transplantation Jang Moon(Mount Sinai, NY, USA)
Åä·Ð 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 10:50~11:00 Discussion ()
ÈÞ½Ä 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 11:00~11:10 Break ()
±âŸ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 11:10~11:40 ±è¼öȯÃß±â°æ°ú ÇÔ²²ÇÑ ¶óÆÄ¿¤ Ŭ¸®´Ð ¾È±Ô¸®(±¹¸³Áß¾ÓÀÇ·á¿ø)
±âŸ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 11:40~12:10 °¡Å縯´ëÇб³ ½ÅÀåÀ̽İú ÀºÆò¼º¸ðº´¿ø Àå±âÀ̽ĺ´¿øÀÇ ³ª¾Æ°¥ ±æ ¾çö¿ì(°¡Å縯ÀÇ´ë)
½Ä»ç 09-03 12:10~13:10 Lunch ()
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 13:10~13:30 Immune tolerence in liver transplantation ÃÖÁ¾¿µ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 13:30~13:50 Expanded criteria for hepatocellular carcinoma in liver transplantation ±èÁ¾¸¸(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 13:50~14:10 ABO-incompatible liver transplantation ¼Û±â¿ø(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 14:10~14:30 Donor ion and safety in living donor Liver Transplantation ¹ÚÁ¤Çö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 14:30~14:45 Complications after heart transplantation - an update ¼¼®¹Î(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 14:45~15:00 Anesthetic consideration post-cardiac transplant recipient ÀüÁØÇ¥(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 15:00~15:15 Current Trends of lung transplantation - optimal strategies for establishmentof program Ãֽÿµ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 15:15~15:30 Pulmonary rehabilitation after lung transplantation ¹ÚÁöÇý(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 15:30~15:45 Experience of starting a lung transplant program ÇÔ¼®Áø(¾ÆÁÖÀÇ´ë)
ÈÞ½Ä 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 15:45~16:00 Break ()
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 16:00~16:30 ±è¼öȯÃß±â°æ°ú °¢¸·ÀÌ½Ä ±è¸¸¼ö(°³²¼º¸ð¿ø¾È°ú)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 16:30~16:45 Impact of Performed and de novo DSA in KT, and Update of Monitoring Strategy ÀÓÁöÇâ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 16:45~17:00 Treatment recommendations for acute and chronic ABMR Á¤º´ÇÏ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 17:00~17:15 Robot-assisted kidney transplantation in immunological high-risk patients ½Å¼º(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09-03 ÀºÆò¼º¸ðº´¿ø GÃþ ´ë°´ç 17:15~17:35 Report of past three year transplants at 'Cadinal Stephen Kim Memorial' Transplant hospital ȲÁ¤±â(°¡Å縯ÀÇ´ë)